Literature DB >> 6251958

Familial pseudohypoparathyroidism without somatic anomalies.

J S Winter, I A Hughes.   

Abstract

A family is described in which affected individuals showed pseudohypoparathyroidism, with hypocalcemia, hyperphosphatemia and increased serum levels of parathyroid hormone, but none of the somatic anomalies frequently associated with this disorder. The untreated individuals showed radiologic evidence of osteitis fibrosa. The administration of parathyroid hormone evoked only a slight increase in the excretion of cyclic adenosine monophosphate but no change in the renal tubular reabsorption of phosphate and no rise in the serum calcium level. The infusion of ethylenediamine tetra-acetic acid caused an appropriate increase in the serum level of parathyroid hormone, but again there was no apparent renal or skeletal response to the hormone. There were no associated abnormalities in calcitonin, thyrotropin or prolactin levels and no thyroid dysfunction. Therapy with vitamin D corrected the hypocalcemia but did not improve the renal and skeletal responsiveness to parathyroid hormone. The inheritance of the disorder in this family was compatible with an autosomal dominant mode with variable penetrance, but other modes could not be excluded.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251958      PMCID: PMC1704543     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  25 in total

1.  HYPO-HYPERPARATHYROIDISM.

Authors:  J M COSTELLO; C E DENT
Journal:  Arch Dis Child       Date:  1963-08       Impact factor: 3.791

2.  Pseudohypoparathyroidism. Disappearance of the resistance to parathyroid extract during treatment with vitamin D.

Authors:  W Stögmann; J A Fischer
Journal:  Am J Med       Date:  1975-07       Impact factor: 4.965

3.  Responsiveness of bone to parathyroid extract in siblings with pseudohypoparathyroidism.

Authors:  K M McDonald
Journal:  Metabolism       Date:  1972-06       Impact factor: 8.694

4.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol.

Authors:  J G Haddad; K J Chyu
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

5.  The assessment of phosphate reabsorption.

Authors:  O L Bijvoet; D B Morgan; P Fourman
Journal:  Clin Chim Acta       Date:  1969-10       Impact factor: 3.786

6.  Immunoassay of human calcitonin.

Authors:  A H Tashijan; B G Howland; K E Melvin; C S Hill
Journal:  N Engl J Med       Date:  1970-10-22       Impact factor: 91.245

7.  Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.

Authors:  S W Kooh; D Fraser; H F DeLuca; M F Holick; R E Belsey; M B Clark; T M Murray
Journal:  N Engl J Med       Date:  1975-10-23       Impact factor: 91.245

8.  Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

Authors:  A L Steiner; D M Kipnis; R Utiger; C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  Normocalcaemic pseudohypoparathyroidism with unusual phenotype.

Authors:  J M Gertner; S Tomlinson; J Gonzalez-Macias
Journal:  Arch Dis Child       Date:  1978-04       Impact factor: 3.791

10.  Prolactin deficiency in pseudohypoparathyroidism.

Authors:  H E Carlson; A S Brickman; G F Bottazzo
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

View more
  9 in total

1.  Pseudohypoparathyroidism-Albright hereditary osteodystrophy.

Authors:  S Rastogi; S Gupta; P K Misra; D Rastogi
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

Review 2.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 3.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

4.  Coexisting primary hyperparathyroidism and Albright's hereditary osteodystrophy--an unusual association.

Authors:  H Sasaki; N Tsutsu; T Asano; T Yamamoto; M Kikuchi; M Okumura
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 5.  Pseudohypoparathyroidism: one gene, several syndromes.

Authors:  O Tafaj; H Jüppner
Journal:  J Endocrinol Invest       Date:  2016-12-19       Impact factor: 4.256

6.  Pseudohypoparathyroidism in a mother and son: phenotypic variability and associated disorder.

Authors:  M Ray; J Goraya; S Basu; S Mitra; B Poddar; V Parmar
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

7.  Pseudohypoparathyroidism type 1B associated with assisted reproductive technology.

Authors:  Monica Fernandez; Maria Jose Zambrano; Joel Riquelme; Claudia Castiglioni; Marie-Laure Kottler; Harald Jüppner; Veronica Mericq
Journal:  J Pediatr Endocrinol Metab       Date:  2017-10-26       Impact factor: 1.634

Review 8.  Molecular Definition of Pseudohypoparathyroidism Variants.

Authors:  Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

9.  Pseudohypoparathyroidism type Ib associated with novel duplications in the GNAS locus.

Authors:  Gustavo Perez-Nanclares; Teresa Velayos; Amaya Vela; Manuel Muñoz-Torres; Luis Castaño
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.